Broach Lifecare Hospital Ltd
₹ 21.5
7.50%
29 May
- close price
About
Incorporated in 2023, Broach Lifecare Hospital Limited operates boutique hospitals under the brand name "Maple Hospitals''.[1]
Key Points
- Market Cap ₹ 13.0 Cr.
- Current Price ₹ 21.5
- High / Low ₹ 52.4 / 0.00
- Stock P/E 24.2
- Book Value ₹ 15.4
- Dividend Yield 0.00 %
- ROCE 9.45 %
- ROE 7.28 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 56.1 to 68.9 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2024 11m | Mar 2025 | |
|---|---|---|---|
| 3.39 | 2.61 | 3.18 | |
| 2.11 | 1.58 | 2.35 | |
| Operating Profit | 1.28 | 1.03 | 0.83 |
| OPM % | 37.76% | 39.46% | 26.10% |
| -0.24 | 0.00 | 0.05 | |
| Interest | 0.09 | 0.00 | 0.03 |
| Depreciation | 0.33 | 0.09 | 0.13 |
| Profit before tax | 0.62 | 0.94 | 0.72 |
| Tax % | 25.81% | 25.53% | 25.00% |
| 0.46 | 0.70 | 0.54 | |
| EPS in Rs | 1.57 | 0.89 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -2% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -8% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.01 | 4.46 | 6.07 |
| Reserves | 2.24 | 1.01 | 3.29 |
| 2.55 | 0.00 | 1.05 | |
| 1.12 | 0.25 | 0.51 | |
| Total Liabilities | 5.92 | 5.72 | 10.92 |
| 4.91 | 1.30 | 1.57 | |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 3.24 |
| 1.01 | 4.42 | 6.11 | |
| Total Assets | 5.92 | 5.72 | 10.92 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 1.11 | -3.22 | -0.62 | |
| -2.79 | -1.48 | -3.64 | |
| 1.63 | 4.77 | 4.38 | |
| Net Cash Flow | -0.05 | 0.07 | 0.12 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 2.15 | 43.35 | 68.87 |
| Inventory Days | 0.00 | 212.92 | |
| Days Payable | 96.32 | ||
| Cash Conversion Cycle | 2.15 | 43.35 | 185.47 |
| Working Capital Days | -71.06 | 144.04 | 272.03 |
| ROCE % | 9.45% |
Documents
Announcements
-
Statement Of Deviation(S) Or Variation(S) Of Funds Raised Through Public Issue For Period Ended On March 31, 2025
30 May - Statement of deviation in IPO funds as per SEBI regulations disclosed on May 30, 2025.
- Submission Of Audited Standalone Financial Results Of The Company Along With The Auditor'S Report For The Half Year And Year Ended March 31, 2025. 30 May
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30, 2025 And Submission Of Audited Standalone Financial Results Of The Company Along With The Auditor'S Report For The Half Year And Year Ended March 31, 2025.
30 May - Audited standalone financial results for half and full year ended March 31, 2025 approved with unmodified auditor opinion.
-
Board Meeting Intimation for To Receive, Consider And Approve The Audited Financial Results For The Half Year And Year Ended On 31St March, 2025 And Any Other Business With Permission Of Chairperson
26 May - Board meeting on May 30, 2025, to approve audited financial results for year ended March 31, 2025.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Broach Lifecare confirms non-applicability of Large Corporate criteria for FY 2024-25 as per SEBI.
Annual reports
No data available.
Business Profile[1] The company offers 24-hour services for heart patients, including non-invasive cardiology tests such as 2D Echocardiography, Electrocardiography, Treadmill Test, Holter Monitoring, Ambulatory Blood Pressure Measurement, Stress Tests, and Dobutamine Stress Echocardiography.